Soocas Announces Neos on Kickstarter, a Revolutionary Dual-Action Brushing and Flossing Electric Toothbrush.

NEW YORK, May 16, 2023 /PRNewswire/ — Soocas announces the release of its revolutionary dual-action brushing and flossing electric toothbrush, Soocas Neos. This electric toothbrush is expected to redefine oral hygiene. With flossing and brushing at the core of its functionality, Soocas Neos can cover and clean more areas of the teeth compared to traditional … Read more

Increasing Digitization & Transition of Care Settings to Outside the Hospital are Disrupting the Industry

DUBLIN, May 16, 2023 /PRNewswire/ — The “Global Medical Devices Outlook, 2023” report has been added to ResearchAndMarkets.com’s offering. The study also offers comprehensive predictions for this space for 2023 and beyond. It identifies the key growth opportunities emerging from these changes for market players to leverage and provides detailed information on market trends, drivers, restraints, … Read more

Global Infectious Diseases Partnering Analysis Report 2023: Featuring a Directory of Over 3,000 Deals

DUBLIN, May 16, 2023 /PRNewswire/ — The “Global Infectious Diseases Partnering 2016-2023: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The Global Infectious Diseases Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 3,000 infectious diseases deals. Most of the deals included within the report occur … Read more

Market to Decrease by a CAGR of 34.01% to 2028

DUBLIN, May 16, 2023 /PRNewswire/ — The “mRNA Vaccine and Therapeutics – Market Insights, Competitive Landscape, and Market Forecast – 2027” report has been added to ResearchAndMarkets.com’s offering. The global mRNA Vaccines and Therapeutics market was valued at USD 71,263 million in 2022, growing at a CAGR of -34.01% during the forecast period from 2023 … Read more

Increasing Prevalence of Brain Disorders is Expected to Propel Growth

Dublin, May 16, 2023 /PRNewswire/ — The “Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global glioblastoma multiforme (GBM) treatment market is expected to grow from $2.04 billion in 2022 … Read more

Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth

DUBLIN, May 16, 2023 /PRNewswire/ — The “Asia-Pacific Next-generation Diagnostics Outlook, 2023” report has been added to  ResearchAndMarkets.com’s offering. The Asia-Pacific next-generation diagnostics market’s revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient … Read more

China Vitamin C E-commerce Market Data Subscription 2023

DUBLIN, May 16, 2023 /PRNewswire/ — The “2023 Vitamin C – Douyin, China E-commerce Market Data Subscription” database has been added to  ResearchAndMarkets.com’s offering. This database subscription gives you all the information you need on the market for Vitamin C supplements in the Chinese market, as measured on the Douyin platform. The data subscription service … Read more

Lateral Flow Assay Components Market size to grow by USD 97.76 million from 2022 to 2027; Growth driven by rising efforts in research and development- Technavio

NEW YORK, May 16, 2023 /PRNewswire/ — The lateral flow assay components market size is set to grow by USD 97.76 million from 2022 to 2027 progressing at a CAGR of 5.22% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market … Read more

Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density

SUZHOU, China, May 16, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces encouraging phase I clinical data of TST002 (Blosozumab) in Chinese patients with reduced bone mineral density (BMD). TST002 (Blosozumab) was well tolerated and significantly … Read more

Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings

ROCKVILLE, Md. and SUZHOU, China, May 16, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today announces that about 30 accepted abstracts of clinical data from multiple trials in relation to … Read more